SPRAVATO® nasal spray adult patient

SPRAVATO®, the only FDA-approved nasal spray for adult patients with two forms of challenging-to-treat major depressive disorder (MDD):

  • Adults with MDD who’ve had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD)
  • Depressive symptoms in adults with MDD with suicidal thoughts or actions (MDSI)

See Limitations of Use below

Nasal spray icon


If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD).

Click arrow icon
Calendar with checkmark icon

Getting Started

If you have treatment-resistant depression (TRD), you may benefit from adding SPRAVATO® to your current oral antidepressant.

Click arrow icon
Cost support icon

Cost Support
& Education

Find a nearby SPRAVATO® treatment center and be prepared with our list of common insurance questions relating to SPRAVATO® coverage.

Click arrow icon